Sorry, you need to enable JavaScript to visit this website.

Press Release Type

Keywords

  • All Keywords

Press Kits

These downloadable files, including fact sheets about Pfizer and approved images or videos, are packages curated by the Global Media Relations team for use by professional journalists.

View Press Kits

Media Contacts

United States, Canada, and Latin America
+1 212.733.1226

Europe, Middle East, and Africa
+44-(0)845.300.8033

Asia Pacific
+65.918.732.47

Email
[email protected]

Though intended for professional media, these resources may also be interesting to patients, healthcare professionals, and investors. The media relations team is focused on responding to media inquiries. However, we want to ensure that customers, investors, and others receive the appropriate attention.

For patients or healthcare professionals with questions about Pfizer’s vaccines or medicines, please see our global list of medical information contacts.

For investors with questions about Pfizer’s efforts, please visit our contact page and select "Shareholder Services".

For all other non-media inquiries, please visit the contact us page to reach the appropriate Pfizer contact.

Your Health

Skipped Childhood Immunizations Could Lead to Resurgence of Vaccine-Preventable Diseases 

Childhood vaccination rates dropped drastically during the COVID-19 pandemic, and it could potentially mean a resurgence of diseases we've long had under control.

Skipped Childhood Immunizations Could Lead to Resurgence of Vaccine-Preventable Diseases 
Your Health

Addressing Disproportionate Childhood Vaccination

Vaccines for children should be available and accessible to all.

Addressing Disproportionate Childhood Vaccination
Science

How Does a Protease Inhibitor Work

The FDA has authorized Pfizer’s COVID-19 oral treatment for emergency use.

How Does a Protease Inhibitor Work